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Studies relating lung function to survival commonly express lung function impairment as
a percent of predicted but this retains age, height and sex bias. We have studied alternative
methods of expressing forced expiratory volume in 1 s (FEV1) for predicting all cause and
airway related lung disease mortality in the Copenhagen City Heart Study data. Cox regression
models were derived for survival over 25 years in 13,900 subjects. Age on entry, sex, smoking
status, body mass index, previous myocardial infarction and diabetes were putative predictors
together with FEV1 either as raw data, standardised by powers of height (FEV1/ht
n), as percent
of predicted (FEV1PP) or as standardised residuals (FEV1SR). Quintiles of FEV1/ht
2 were better
at predicting all cause mortality in multivariate models than FEV1PP and FEV1SR, with the
hazard ratio (HR) for the worst quintiles being 2.8, 2.0 and 2.1 respectively. Cut levels of lung
function were used to categorise impairment and the HR for multivariate prediction of all
cause and airway related lung disease mortality were 10 and 2044 respectively for the worst
category of FEV1/ht
2 compared to 5 and 194 respectively for the worst category of FEV1PP.
In univariate predictions of all cause mortality the HR for FEV1/ht
2 categories was 2e4 times
higher than those for FEV1PP and 3e10 times higher for airway related lung disease mortality.
We conclude that FEV1/ht
2 is superior to FEV1PP for predicting survival in a general population
and this method of expressing FEV1 impairment best reflects hazard for subsequent death.
ª 2008 Elsevier Ltd. All rights reserved.21 627 8479; fax: þ44 121 627 8292.
.nhs.uk (M.R. Miller).
8 Elsevier Ltd. All rights reserved.
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In general population studies it has been found that lung
function in terms of forced expiratory volume in 1 s (FEV1)
is a strong predictor of all cause mortality.1e3 Often the
value for FEV1 has been expressed as percent of predicted
in an attempt to adjust for age, height and sex by using an
accepted prediction equation. In adjusting the measure of
lung function in this way it is hoped that the signal in the
measure is enhanced. However, prediction equations can
introduce an error because at best they only account for
about 70% of the variation seen within a population4 and
both the population and the equipment used to record lung
function are rarely a perfect match for the subjects in
question. Thus, both the value predicted for an individual
and the percent predicted values are only estimates and
not precise statements of fact.
In patients with chronic obstructive pulmonary disease
(COPD) it was found over 35 years ago that raw FEV1 was
a strong predictor of mortality.5 The Framingham study
found that FEV1/ht
2 was a good predictor of survival2 and
this method of data presentation has previously been used
when studying COPD6 with recent studies showing this to be
the best predictor of mortality in COPD7 and in the general
population,8 with the latter study raising the question
whether standardising FEV1 by height cubed might be
better than FEV1/ht
2. Therefore, we have looked at the
large data set from the Copenhagen City Heart Study to
determine the best method for expressing FEV1 with regard
to obtaining the best prediction of survival.Table 1 Mean and SD for data on entry to the study for
the 7521 women and 6379 men.
Women (nZ 7521) Men (nZ 6379)
Mean SD Mean SD
Age 52.8 11.6 53.2 12.3
Height m 1.62 0.06 1.74 0.07
FEV1 L 2.22 0.59 2.98 0.90
FEV1SR 0.66 1.19 0.90 1.30
FEV1PP 90.0 18.8 86.0 19.9
FEV1/ht
2 0.84 0.20 0.98 0.27
FEV1/ht
3 0.52 0.12 0.56 0.15
FEV1/ht
4 0.32 0.08 0.32 0.09
FVC L 2.76 0.66 3.79 0.98
FVCSR 0.30 1.12 0.79 1.17
FVCPP 95.5 16.9 88.2 17.0
FEV1% 80.1 9.6 78.2 11.4
FEV1%SR 0.17 1.46 0.07 1.54
FEV1%PP 101.4 12.1 100.7 14.4
BMI kg/m2 24.7 4.4 25.8 3.7Methods
The data from 13,929 subjects entered into the Copenha-
gen City Heart Study in 1976e1978 were released for
analysis. The methods and background to this large project
have been previously described.3,9 Age and height on entry
to the study, spirometry values and data of the cause of
death up to December 2002 were available. FEV1 and forced
vital capacity (FVC) had been recorded whilst sitting using
a Vitalograph bellows spirometer (Maids Moreton, Buck-
ingham, UK). Only recordings with at least two measure-
ments of FEV1 within 5% of each other were used. The
highest values obtained were recorded. Any subject whose
recorded FEV1 was below 0.3 L or whose FEV1 exceeded FVC
was excluded leaving 13,900 subjects for the analysis.
Predicted values were derived using equations recom-
mended by the European Respiratory Society4 with an age
of 25 entered for any subject under 25. Those subjects aged
over 70 had predictions made even though these were
outside the accepted range for using these equations. FEV1
was then expressed as the percent of predicted (FEV1PP)
and as standardised residuals (FEV1SR).
4 Alternative
methods for standardising FEV1 for size and sex were by
dividing FEV1 by height to the power of n (FEV1/ht
n).
In all those subjects where data were available on the
exact cause of death those subjects were identified who
had a cause including any one of the following: chronic
bronchitis, COPD, acute exacerbation of chronic bronchitis
or COPD, emphysema, or asthma. Analyses for predictingdeaths from these airway related lung diseases were then
undertaken.
Statistics
Cox regression models were derived using Stata/SE version
9.1. Sex, smoking status, previous myocardial infarction
and presence of diabetes mellitus were included as cate-
gorical variables. Initial univariate models were derived
using indices as continuous variables and chi square values
were from a comparison with a null model. Multivariate
models were then derived using quintiles of age, body mass
index (BMI), and lung function indices; so hazard ratios for
different levels of each index could be derived. Models
were compared with each other using a likelihood-ratio
test. Cut levels, using the mean value and numbers of
standard deviations (SD) from the mean, for each method
of standardising FEV1 were then used to categorise the
degree of impairment and used in multivariate and
univariate Cox regression. Hazard ratios (HR) were calcu-
lated relative to the survival of the first quintile (highest
lung function, lowest age and lowest BMI) or for analysis
using cut levels for lung function indices the hazard ratios
were relative to those subjects with their index -
meanþ 1.0 SD. Putative predictors for death were
accepted with a 5% probability for falsely rejecting the null
hypothesis.
Results
There were data available from 6379 men and 7521 women
and their data on entry to the study are shown in Table 1.
To determine the best power relationship between FEV1
and height a linear regression analysis was undertaken of
the natural log of FEV1 against the natural log of height
using the data for both sexes together with the slope of
3.73 (r2Z 0.57) being the best power fit for these data. We
therefore considered standardising FEV1 by height to the
Table 3 Results from univariate Cox regression models for
either all cause mortality or airway related lung disease
deaths (respiratory) expressed as chi square values for
putative predictors derived from a comparison with a null
model. MI indicates previous myocardial infarction, BMI
denotes body mass index (kg/m2), DM denotes suffering
from diabetes mellitus, and smoking denotes if the subject
had ever been a smoker.
All cause Respiratory
Age 5350 FEV1/ht
3 776
FEV1/ht
3 2657 FEV1/ht
2 757
FEV1/ht
4 2633 FEV1/ht
4 756
FEV1/ht
2 2466 FEV1PP 723
FEV1 1788 FEV1 630
FVC 1183 FEV1SR 542
FEV1PP 1097 FEV1% 457
FVCPP 1024 FVCPP 402
FVCSR 765 FEV1%PP 383
FEV1SR 711 FEV1%SR 366
FEV1% 692 FVCSR 322
Sex 423 FVC 312
MI 410 Age 212
Smoking 256 Smoking 87
BMI 251 Sex 14
DM 164 BMI 10
FEV1%PP 127
FEV1%SR 123
444 M.R. Miller et al.powers of 2, 3 and 4 to determine the best power rela-
tionship in these data. The skewness and kurtosis of the
distributions of height and the various ways of expressing
the lung function index are shown in Table 2, where
a positive (or right) skewness indicates that the bulk of data
are to the left with a long tail to the right of the distribution
and a positive kurtosis indicates that the variance in the
distribution is mainly due to infrequent extreme deviations
with a narrow tall peak around the mean. Both skewness
and kurtosis for a Gaussian distribution should be close to
zero. Height was a random variable on entry to the study
and has only slight skewness or kurtosis in either sex taken
separately which was the same for raw FEV1. When ana-
lysing both sexes together the skewness and kurtosis values
were, as expected, least acceptable for raw FEV1 but they
were also unacceptable for FEV1PP and FEV1SR with the
distributions negatively skewed and more peaked and with
broader tails than a Gaussian distribution. The best distri-
butions were for FEV1/ht
n with the height cubed being
slightly better than with the height squared.
During the period of follow up to December 2002 there
were 3912 deaths in the males (61.3%) and 3314 deaths in
the females (44.1%). Details on the cause of death were
available for 6384 of the 7226 subjects who had died and of
these 349 (171 females) had a cause of death that was due
to airway related lung disease.
The results from the univariate analysis using Cox
regression for predicting death with lung function and age
as continuous variables are shown in Table 3. Age and then
FEV1/ht
3 were the best univariate predictors for all cause
mortality; FEV1/ht
3 and FEV1/ht
2 were the best two
univariate predictors for mortality due to airway related
lung disease.
Cox multivariate regression models to predict all cause
mortality were then prepared with quintiles of age and BMI,
the presence of diabetes mellitus on entry to the study,
previous heart attack prior to entry to the study, smoking
status on entry to the study and sex as obligatory predic-
tors. The best model was then selected with the lung
function taken from quintiles of FEV1, FEV1PP, FEV1SR,
FEV1/ht
2, FEV1/ht
3 or FEV1/ht
4. The FEV1/ht
3 model was
significantly better than all other models (p< 0.04, likeli-
hood-ratio test) except for the FEV1/ht
2 model (pZ 0.5).
The results for the FEV1/ht
2, FEV1, FEV1PP and FEV1SR
models are shown in Table 4. The hazard ratios (HR) for age
in the models with FEV1PP and FEV1SR were much largerTable 2 Skewness and kurtosis values for the distributions for
13,900 subjects taken together and the men and women separat
All subjects Men
Skewness Kurtosis Skewn
Height 0.17 0.31 0.10
FEV1 0.57 0.50 0.14
FEV1PP 0.27 0.70 0.38
FEV1SR 0.26 0.63 0.25
FEV1/ht
2 0.14 0.23 0.10
FEV1/ht
3 0.00 0.20 0.13
FEV1/ht
4 0.02 0.23 0.09than those for the other models and conversely the hazard
ratios for the quintiles of lung function indices were lower,
with the 2nd best quintile HR for FEV1PP not being signifi-
cantly different from that of the best quintile.
When predicting deaths from airway related lung
diseases the presence of diabetes mellitus and previous
myocardial infarction were no longer significant predictors.
The results are shown in Table 5 with the models for FEV1/
ht2, FEV1 and FEV1PP not being significantly different from
each other and only FEV1/ht
2 was better than that for
FEV1SR (p< 0.03, likelihood-ratio test). The HR for age in
the models with FEV1PP and FEV1SR was up to five times
larger than those in the better models and the HR for
FEV1PP was not significantly different from unity in the 2nd
and 3rd best quintiles. The HR for male sex was much lower
in the FEV1PP and FEV1SR models.height, FEV1 and the various ways of expressing FEV1 for all
ely.
Women
ess Kurtosis Skewness Kurtosis
0.14 0.06 0.14
0.16 0.18 0.16
0.62 0.12 0.62
0.69 0.23 0.69
0.13 0.02 0.13
0.18 0.03 0.18
0.25 0.04 0.25
Table 4 Results for multivariate Cox regression models for predicting death from all causes with men and women considered
together. The c2 values are for each model compared with a null model and are given as an index of which gave the best
prediction. Hazard ratios (HR) for the predictor variables are shown with their 95% confidence limits (CL). The best model is to
the left and the least good to the right.
FEV1/ht
2 (c2 6367) FEV1 (c
2 6354) FEV1PP (c
2 6270) FEV1SR (c
2 6230)
HR 95% CL HR 95% CL HR 95% CL HR 95% CL
Sex Female 1 1 1 1
Male 2.1 (1.9e2.2) 2.4 (2.2e2.5) 1.6 (1.5e1.7) 1.6 (1.5e1.7)
Age Youngest quintile 1 1 1 1
Quintile 2 2.3 (2.1e2.6) 2.4 (2.1e2.7) 2.6 (2.3e2.9) 2.7 (2.4e3.0)
Quintile 3 3.9 (3.4e4.4) 4.0 (3.5e4.5) 4.8 (4.2e5.3) 4.9 (4.4e5.5)
Quintile 4 5.7 (5.1e6.4) 5.7 (5.1e6.4) 7.5 (6.7e8.4) 7.9 (7.1e8.8)
Oldest quintile 11.2 (9.9e12.6) 11.3 (10.0e12.7) 16.4 (14.6e18.3) 17.7 (15.8e19.8)
Diabetic 2.1 (1.8e2.4) 2.2 (1.9e2.5) 2.1 (1.9e2.4) 2.1 (1.9e2.5)
Previous MI 2.1 (1.9e2.4) 2.1 (1.9e2.4) 2.1 (1.9e2.4) 2.2 (1.9e2.4)
Current smoker 1.6 (1.5e1.7) 1.6 (1.5e1.7) 1.6 (1.5e1.7) 1.6 (1.5e1.7)
BMI Lightest quintile 1 1 1 1
Quintile 2 0.8 (0.8e0.9) 0.8 (0.8e0.9) 0.8 (0.8e0.9) 0.8 (0.8e0.9)
Quintile 3 0.8 (0.8e0.9) 0.8 (0.8e0.9) 0.8 (0.8e0.9) 0.8 (0.8e0.9)
Quintile 4 0.9 (0.9e1.0) 0.9 (0.9e1.0) 0.9 (0.9e1.0) 0.9 (0.9e1.0)
Heaviest quintile 1.1 (1.0e1.1) 1.0 (1.0e1.1) 1.1 (1.0e1.2) 1.1 (1.0e1.2)
FEV1 index Best quintile 1 1 1 1
Quintile 2 1.4 (1.3e1.5) 1.3 (1.2e1.4) 1.1 (1.0e1.2) 1.1 (1.0e1.2)
Quintile 3 1.6 (1.4e1.7) 1.5 (1.4e1.7) 1.2 (1.1e1.3) 1.2 (1.1e1.4)
Quintile 4 1.9 (1.7e2.1) 1.9 (1.7e2.0) 1.4 (1.3e1.6) 1.5 (1.3e1.6)
Worst quintile 2.8 (2.5e3.1) 2.8 (2.6e3.1) 2.0 (1.9e2.2) 2.1 (1.9e2.2)
Table 5 Results for multivariate Cox regression models for predicting death from airway related lung diseases with men and
women considered together. The c2 values are for each model compared with the null model and are given as an index of which
gave the best prediction. Hazard ratios (HR) for the predictor variables are shown with their 95% confidence limits (CL). The best
model is to the left and the least good to the right.
FEV1/ht
2 (c2 792) FEV1 (c
2 781) FEV1PP (c
2 780) FEV1SR (c
2 765)
HR 95% CL HR 95% CL HR 95% CL HR 95% CL
Sex Female 1 1 1 1
Male 3.4 (2.7e4.3) 5.8 (4.6e7.3) 1.6 (1.3e2.0) 1.5 (1.2e1.9)
Age Youngest quintile 1 1 1 1
Quintile 2 3.3 (1.7e6.6) 3.2 (1.6e6.3) 5.0 (2.5e9.9) 5.8 (3.0e11.5)
Quintile 3 4.4 (2.2e8.7) 4.4 (2.2e8.6) 9.1 (4.7e17.6) 11.8 (6.1e22.7)
Quintile 4 6.1 (3.1e12.0) 5.7 (2.9e11.3) 15.6 (8.1e29.9) 22.3 (11.6e42.8)
Oldest quintile 6.0 (3.0e11.9) 6.0 (3.0e12.1) 21.6 (11.1e42.0) 34.9 (18.0e67.7)
Current smoker 2.2 (1.7e2.9) 2.3 (1.7e3.0) 2.0 (1.5e2.7) 2.0 (1.5e2.7)
BMI Lightest quintile 1 1 1 1
Quintile 2 0.7 (0.5e0.9) 0.7 (0.5e0.9) 0.7 (0.5e1.0) 0.7 (0.5e0.9)
Quintile 3 0.4 (0.3e0.6) 0.4 (0.3e0.6) 0.4 (0.3e0.6) 0.4 (0.3e0.6)
Quintile 4 0.5 (0.3e0.6) 0.4 (0.3e0.6) 0.4 (0.3e0.6) 0.5 (0.3e0.6)
Heaviest quintile 0.4 (0.3e0.5) 0.4 (0.3e0.5) 0.4 (0.3e0.6) 0.4 (0.3e0.6)
FEV1 index Best quintile 1 1 1 1
Quintile 2 2.2 (1.0e4.8) 1.5 (0.7e3.1) 1.5 (0.7e2.9) 1.3 (0.6e2.5)
Quintile 3 3.2 (1.5e6.6) 4.0 (2.1e7.8) 1.8 (0.9e3.4) 2.0 (1.1e3.8)
Quintile 4 7.5 (3.7e15.2) 8.5 (4.5e16.0) 4.2 (2.4e7.6) 5.0 (2.8e8.8)
Worst quintile 36.8 (18.8e72.2) 38.7 (21.0e71.1) 19.0 (11.0e32.7) 19.0 (11.0e32.7)
Table 6 Values for the mean and multiples of SD within
the population for three methods of standardising FEV1.
FEV1/ht
2 FEV1/ht
3 FEV1PP
Meanþ 1.0 SD 1.15 0.68 107.6
Meanþ 0.5 SD 1.03 0.61 97.8
Mean (SD) 0.91 (0.24) 0.54 (0.14) 88.1 (19.4)
Mean 0.5 SD 0.78 0.47 78.4
Mean 1.0 SD 0.66 0.40 68.7
Mean 1.5 SD 0.54 0.33 59.0
Mean 2.0 SD 0.42 0.26 49.3
Mean 2.5 SD 0.29 0.19 39.6
Mean 3.0 SD 0.17 0.13 29.9
446 M.R. Miller et al.Cut levels were derived for FEV1/ht
2, FEV1/ht
3 and
FEV1PP from conventional statistics for Gaussian distribu-
tions as shown in Table 6 as these might prove more useful
than the quintile values for use in clinical situations.
Multivariate Cox regression models were constructed with
each index divided into groups using these cut levels with
the FEV1/ht
2 model being significantly better than the
other two (p< 0.0001, likelihood-ratio test). Fig. 1 shows
the numbers of subjects in each group on the right hand
ordinate scale together with the corresponding hazard ratio
from the multivariate analysis for all cause mortality on the
left hand ordinate scale. FEV1/ht
2 outperformed both the
other two methods in terms of the hazard ratio associated
with the cut points defined by the numbers of SD from the
mean value for the group. The hazard ratio for the worst
group in each index was 10 for FEV1/ht
2, 6 for FEV1/ht
3 and 5
for FEV1PP. The results for the multivariate prediction of
mortality from airway related lung disease found that the<(M
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Figure 1 Plot of numbers of subjects identified in various
groupings, together with their hazard ratios for all cause
mortality, based on the deviation from the mean value for FEV1
when standardised by height squared (circles), by height cubed
(triangles) and by percent of predicted (squares). Open
symbols are for the number of subjects with the right hand
ordinate scale and closed symbols are for the hazard ratio on
the left hand ordinate scale. Hazard ratios were derived from
multivariate Cox models including quintiles of age and BMI,
smoking status, MI and DM.models for FEV1/ht
2, FEV1/ht
3 and FEV1PP were not signifi-
cantly different from each other although the HR for the
worst groups were 2044, 699 and 194 respectively. In clinical
practice a recording of FEV1 may be used to help guide
survival prediction and Table 7 shows the results for
univariate Cox models using these cut level categories of
FEV1/ht
2 and FEV1PP. The FEV1/ht
2 models were signifi-
cantly better at predicting both all cause and airway related
lung disease mortality (p< 0.0004, likelihood-ratio test).Discussion
We have shown in a very large epidemiological study of
predictors of all cause and airway related lung disease
mortality that the predictive value of lung function is best
expressed by standardising FEV1 by height squared. FEV1
expressed as percent of predicted yielded less good
predictions of survival and very different estimates of the
effect of age and sex on survival.
The failure of the percent of predicted method to give
the best model may be for a number of reasons. Whenever
making a prediction of lung function for an individual there
is an error in this estimate. The predicted value has confi-
dence limits based on wide population variations. For
a given age, height and sex the 90% confidence limits for
predicting FEV1 are 0.839 L (0.51 1.645) in men and
0.625 L (0.38 1.645) in women.4 This level of variation is
the same for younger taller subjects (who have a higher
predicted value) and for shorter older subjects (who have
a lower predicted value). Thus the 90% confidence limits for
FEV1 when expressed as the percent of predicted vary with
age, height and also with sex. Therefore, the very reason to
relate to a predicted value (to remove age, sex and height
bias) is in part defeated by using the proportional rela-
tionship implicit in the method of percent predicted.
However, the method of standardised residuals, which is
the preferred method for determining lower limits of
normal range, is also not an ideal method for expressing the
degree of abnormality since the young and tall with a high
predicted value can drop 6 or more SR and still have
a recordable FEV1 whereas for the short and elderly the
predicted value is already low and there is only ‘room’ for
FEV1 to drop by 2 or 3 SR before FEV1 reaches zero. We have
found (results not presented) when analysing the data from
men and women separately that raw FEV1 is superior to the
percent predicted for predicting survival indicating that the
above biases introduced into the PP method reduce its
usefulness in predicting survival.
An important finding in the improved prediction models
using FEV1/ht
2 is that the hazard ratios for age and sex are
different from the less good model with FEV1PP. The age of
a subject cannot vary in the same way as other true vari-
ables, since it is defined by the moment of birth and
increases inexorably and monotonically with time. True
variables may increase or decrease in response to various
influences, with some of these being time related. Lung
function is influenced by age and sex,4 by body size and
body weight,10 by atmospheric pollution from the environ-
ment,11e14 by smoking,15,16 by diet17e19 and by therapy.
The effect of the environment, smoking and diet can be
related to time or duration of the influence and so age can
Table 7 Hazard ratios with their 95% confidence limits for death from all causes and from airway related lung disease
(respiratory) in univariate Cox regression models using specified cut points for FEV1/ht
2 and FEV1PP derived from the distribution
of each index with the number of subjects (Num) for each group.
FEV1/ht
2 FEV1PP
Num All cause Respiratory Num All cause Respiratory
HR 95% CL HR 95% CL HR 95% CL HR 95% CL
(Meanþ 1.0 SD) 2159 1 1 1974 1 1
(Meanþ 0.5 SD) 1931 1.7 (1.5e1.9) 4.2 (1.5e11.3) 2287 1.0 (0.9e1.1) 0.8 (0.3e1.8)
Mean 2678 2.2 (2.0e2.3) 4.3 (1.6e11.4) 3003 1.1 (1.0e1.2) 1.6 (0.8e3.2)
(Mean 0.5 SD) 2862 2.8 (2.6e3.1) 7.1 (2.8e118.1) 2708 1.4 (1.3e1.5) 2.9 (1.5e5.7)
(Mean 1.0 SD) 2163 4.1 (3.7e4.5) 20.5 (8.2e50.7) 1918 1.9 (1.7e2.0) 7.5 (4.0e14.2)
(Mean 1.5 SD) 1256 5.6 (5.0e6.2) 45.6 (18.4e112.8) 1025 2.5 (2.3e2.8) 14.9 (7.8e28.4)
(Mean 2.0 SD) 522 8.1 (7.1e9.2) 116.0 (46.4e290.2) 515 3.3 (3.0e3.7) 25.8 (13.2e50.2)
(Mean 2.5 SD) 248 9.2 (7.8e10.7) 213.6 (84.5e540.0) 249 3.7 (3.2e4.4) 63.7 (32.9e123.2)
(Mean 3.0 SD) 74 16.7 (13.0e21.3) 786.2 (300.0e2060.9) 152 4.7 (4.0e5.7) 88.3 (44.2e176.5)
<(Mean 3.0 SD) 7 32.8 (15.5e69.2) 3091.3 (727.1e13,142.7) 69 8.2 (6.4e10.5) 286.6 (139.7e587.8)
Survival prediction from lung function data 447be a surrogate marker for this exposure or effect. From the
age of about 25 lung function declines with increasing age
and the exact determinants of the rate of decline are of
considerable interest. Various disease states, such as
asthma20 and COPD,16 are known to be associated with an
increased rate of lung function decline. How much of this is
genetically determined21 or exposure related is not fully
known. These effects on FEV1 and its ability to predict
survival in our subjects appear to be better reflected by
using FEV1/ht
2 (which will take some sex and size differ-
ence into account) and to make no attempt at accounting
for sex, age and height effects on lung function by using
conventional prediction equations.4 More of the predictive
effect on survival is then evidenced in the FEV1 index and
less is attributed to age.
Previous workers have used8 FEV1/ht
2 and our data
suggest that a higher power relationship for standardising
by height is not importantly better for predicting mortality.
Although multivariate models predicting survival with FEV1/
ht3 were slightly but not significantly better than FEV1/ht
2
when the analysis looked at cut levels of the indices and
their relation to hazard ratio for mortality FEV1/ht
2 was
a much better descriptor of lung function impairment.
We conclude that the use of percent of predicted for
lung function indices such as FEV1 is not the best method
for describing the degree of lung function impairment with
regard to mortality. If the percent of predicted method is
used in studies to determine the effect of lung function on
survival then less good models are obtained and undue
influence may be given to age per se rather than to the true
time related effects on lung function that are so important
in determining survival in an individual subject. We have
confirmed that standardising FEV1 by height squared gives
the best survival prediction in the general population and is
best for predicting airway related lung disease mortality. It
has also been shown to give better disease stratification for
COPD7 than using the percent of predicted method such as
that suggested by GOLD.22 FEV1/ht
2 may also lead to better
estimates of survival if it is used instead of FEV1PP in
multivariate predictions such as in the BODE index for
COPD.23Conflict of interest statement
None of the authors has any financial or personal relation-
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